目次

Table of Contents

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Application
Market segments
Comparison by Application
Solid tumors - Market size and forecast 2020-2025
Blood-related tumors - Market size and forecast 2020-2025
Market opportunity by Application

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Agenus Inc.
Amgen Inc.
AnaptysBio Inc.
AstraZeneca Plc
BeiGene Ltd.
Bristol-Myers Squibb Co.
Checkpoint Therapeutics Inc.
F. Hoffmann-La Roche Ltd.
Merck and Co. Inc.
Pfizer Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Application - Market share 2020-2025 (%)
22: Comparison by Application
23: Solid tumors - Market size and forecast 2020-2025 ($ million)
24: Solid tumors - Year-over-year growth 2020-2025 (%)
25: Blood-related tumors - Market size and forecast 2020-2025 ($ million)
26: Blood-related tumors - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Application
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Agenus Inc. - Overview
48: Agenus Inc. - Business segments
49: Agenus Inc. - Key offerings
50: Agenus Inc. - Key customers
51: Agenus Inc. - Segment focus
52: Amgen Inc. - Overview
53: Amgen Inc. - Business segments
54: Amgen Inc. - Key offerings
55: Amgen Inc. - Key customers
56: Amgen Inc. - Segment focus
57: AnaptysBio Inc. - Overview
58: AnaptysBio Inc. - Business segments
59: AnaptysBio Inc. - Key offerings
60: AnaptysBio Inc. - Key customers
61: AnaptysBio Inc. - Segment focus
62: AstraZeneca Plc - Overview
63: AstraZeneca Plc - Product and service
64: AstraZeneca Plc - Key offerings
65: AstraZeneca Plc - Key customers
66: AstraZeneca Plc - Segment focus
67: BeiGene Ltd. - Overview
68: BeiGene Ltd. - Product and service
69: BeiGene Ltd. - Key offerings
70: BeiGene Ltd. - Key customers
71: BeiGene Ltd. - Segment focus
72: Bristol-Myers Squibb Co. - Overview
73: Bristol-Myers Squibb Co. - Product and service
74: Bristol-Myers Squibb Co. - Key offerings
75: Bristol-Myers Squibb Co. - Key customers
76: Bristol-Myers Squibb Co. - Segment focus
77: Checkpoint Therapeutics Inc. - Overview
78: Checkpoint Therapeutics Inc. - Business segments
79: Checkpoint Therapeutics Inc. - Key offerings
80: Checkpoint Therapeutics Inc. - Key customers
81: Checkpoint Therapeutics Inc. - Segment focus
82: F. Hoffmann-La Roche Ltd. - Overview
83: F. Hoffmann-La Roche Ltd. - Business segments
84: F. Hoffmann-La Roche Ltd. - Key offerings
85: F. Hoffmann-La Roche Ltd. - Key customers
86: F. Hoffmann-La Roche Ltd. - Segment focus
87: Merck and Co. Inc. - Overview
88: Merck and Co. Inc. - Business segments
89: Merck and Co. Inc. - Key offerings
90: Merck and Co. Inc. - Key customers
91: Merck and Co. Inc. - Segment focus
92: Pfizer Inc. - Overview
93: Pfizer Inc. - Business segments
94: Pfizer Inc. - Key offerings
95: Pfizer Inc. - Key customers
96: Pfizer Inc. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations